Chinatsu Arima

1.2k total citations
15 papers, 897 citations indexed

About

Chinatsu Arima is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Chinatsu Arima has authored 15 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Chinatsu Arima's work include RNA modifications and cancer (4 papers), Lung Cancer Treatments and Mutations (4 papers) and MicroRNA in disease regulation (3 papers). Chinatsu Arima is often cited by papers focused on RNA modifications and cancer (4 papers), Lung Cancer Treatments and Mutations (4 papers) and MicroRNA in disease regulation (3 papers). Chinatsu Arima collaborates with scholars based in Japan, United States and France. Chinatsu Arima's co-authors include Takashi Takahashi, Shuta Tomida, Yukako Shimada, Yasushi Yatabe, Kiyoshi Yanagisawa, Motoshi Suzuki, Toshiyuki Takeuchi, Hirotaka Osada, Tetsuya Mitsudomi and Tomoya Yamaguchi and has published in prestigious journals such as Journal of Clinical Oncology, The EMBO Journal and PLoS ONE.

In The Last Decade

Chinatsu Arima

15 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chinatsu Arima Japan 13 625 328 272 266 67 15 897
Yukako Shimada Japan 15 806 1.3× 427 1.3× 330 1.2× 333 1.3× 106 1.6× 18 1.1k
Maxime Tarabichi Belgium 16 574 0.9× 351 1.1× 222 0.8× 187 0.7× 64 1.0× 28 1.1k
Henri Sara Finland 9 664 1.1× 280 0.9× 238 0.9× 191 0.7× 62 0.9× 11 883
Claudia Hube‐Magg Germany 21 630 1.0× 300 0.9× 260 1.0× 370 1.4× 53 0.8× 60 1.0k
Philip G. Febbo United States 8 644 1.0× 265 0.8× 215 0.8× 451 1.7× 43 0.6× 15 1.0k
Huawei Zou China 16 403 0.6× 322 1.0× 244 0.9× 163 0.6× 39 0.6× 36 710
Áron Bartha Hungary 5 461 0.7× 221 0.7× 218 0.8× 168 0.6× 73 1.1× 8 685
Angelo Gámez‐Pozo Spain 15 427 0.7× 257 0.8× 169 0.6× 151 0.6× 45 0.7× 51 718
Bianca den Hamer Netherlands 10 819 1.3× 210 0.6× 167 0.6× 234 0.9× 40 0.6× 15 1.0k
Zhi-Ming Shao China 7 464 0.7× 365 1.1× 360 1.3× 222 0.8× 39 0.6× 10 862

Countries citing papers authored by Chinatsu Arima

Since Specialization
Citations

This map shows the geographic impact of Chinatsu Arima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chinatsu Arima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chinatsu Arima more than expected).

Fields of papers citing papers by Chinatsu Arima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chinatsu Arima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chinatsu Arima. The network helps show where Chinatsu Arima may publish in the future.

Co-authorship network of co-authors of Chinatsu Arima

This figure shows the co-authorship network connecting the top 25 collaborators of Chinatsu Arima. A scholar is included among the top collaborators of Chinatsu Arima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chinatsu Arima. Chinatsu Arima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Tai, Mei-Chee, Taisuke Kajino, Masahiro Nakatochi, et al.. (2016). miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer. Journal of Thoracic Oncology. 11(2). S48–S48. 8 indexed citations
2.
Tai, Mei-Chee, Taisuke Kajino, Masahiro Nakatochi, et al.. (2015). miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer. Carcinogenesis. 36(12). bgv152–bgv152. 43 indexed citations
3.
Arima, Chinatsu, Taisuke Kajino, Yoshinori Tamada, et al.. (2014). Lung adenocarcinoma subtypes definable by lung development-related miRNA expression profiles in association with clinicopathologic features. Carcinogenesis. 35(10). 2224–2231. 35 indexed citations
4.
Yamaguchi, Tomoya, Kiyoshi Yanagisawa, Yasuyuki Hosono, et al.. (2012). NKX2-1/TITF1/TTF-1-Induced ROR1 Is Required to Sustain EGFR Survival Signaling in Lung Adenocarcinoma. Cancer Cell. 21(3). 348–361. 207 indexed citations
5.
Yanagisawa, Kiyoshi, Shuta Tomida, Keitaro Matsuo, et al.. (2012). Seven-Signal Proteomic Signature for Detection of Operable Pancreatic Ductal Adenocarcinoma and Their Discrimination from Autoimmune Pancreatitis. PubMed. 2012. 1–11. 4 indexed citations
6.
Hosono, Yasuyuki, Tomoya Yamaguchi, Kiyoshi Yanagisawa, et al.. (2011). MYBPH, a transcriptional target of TTF‐1, inhibits ROCK1, and reduces cell motility and metastasis. The EMBO Journal. 31(2). 481–493. 72 indexed citations
7.
Matsuyama, Yasushi, Motoshi Suzuki, Chinatsu Arima, et al.. (2011). Proteasomal non‐catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas. Molecular Carcinogenesis. 50(4). 301–309. 47 indexed citations
8.
Nishikawa, Eri, Hirotaka Osada, Yasumasa Okazaki, et al.. (2011). miR-375 Is Activated by ASH1 and Inhibits YAP1 in a Lineage-Dependent Manner in Lung Cancer. Cancer Research. 71(19). 6165–6173. 115 indexed citations
9.
Yanagisawa, Kiyoshi, Hiroyuki Konishi, Chinatsu Arima, et al.. (2010). Novel Metastasis-Related Gene CIM Functions in the Regulation of Multiple Cellular Stress–Response Pathways. Cancer Research. 70(23). 9949–9958. 22 indexed citations
10.
Huang, Qin, Shuta Tomida, Yuji Masuda, et al.. (2010). Regulation of DNA Polymerase POLD4 Influences Genomic Instability in Lung Cancer. Cancer Research. 70(21). 8407–8416. 40 indexed citations
11.
Kim, Sinae, Guoan Chen, Christian Brambilla, et al.. (2010). Clinically Relevant Characterization of Lung Adenocarcinoma Subtypes Based on Cellular Pathways: An International Validation Study. PLoS ONE. 5(7). e11712–e11712. 44 indexed citations
12.
Ebi, Hiromichi, Shuta Tomida, Toshiyuki Takeuchi, et al.. (2009). Relationship of Deregulated Signaling Converging onto mTOR with Prognosis and Classification of Lung Adenocarcinoma Shown by Two Independent In silico Analyses. Cancer Research. 69(9). 4027–4035. 31 indexed citations
13.
Tomida, Shuta, Toshiyuki Takeuchi, Yukako Shimada, et al.. (2009). Relapse-Related Molecular Signature in Lung Adenocarcinomas Identifies Patients With Dismal Prognosis. Journal of Clinical Oncology. 27(17). 2793–2799. 193 indexed citations
14.
Arima, Chinatsu, et al.. (2008). Modified Fuzzy Gap statistic for estimating preferable number of clusters in Fuzzy k-means clustering. Journal of Bioscience and Bioengineering. 105(3). 273–281. 24 indexed citations
15.
Arima, Chinatsu, Taizo Hanai, & Masahiro Okamoto. (2003). Gene Expression Analysis Using Fuzzy K-Means Clustering. Proceedings Genome Informatics Workshop/Genome informatics. 14. 334–335. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026